Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Healthcare Triangle (HCTI) EBITDA (2020 - 2025)

Healthcare Triangle's EBITDA history spans 6 years, with the latest figure at -$2.6 million for Q3 2025.

  • For Q3 2025, EBITDA fell 107.22% year-over-year to -$2.6 million; the TTM value through Sep 2025 reached -$5.8 million, down 2.8%, while the annual FY2024 figure was -$4.7 million, 38.29% up from the prior year.
  • EBITDA for Q3 2025 was -$2.6 million at Healthcare Triangle, down from -$1.4 million in the prior quarter.
  • Across five years, EBITDA topped out at $469000.0 in Q2 2021 and bottomed at -$10.6 million in Q4 2022.
  • The 5-year median for EBITDA is -$1.5 million (2023), against an average of -$2.1 million.
  • The largest annual shift saw EBITDA plummeted 1025.2% in 2021 before it soared 87.48% in 2023.
  • A 5-year view of EBITDA shows it stood at -$3.3 million in 2021, then plummeted by 220.06% to -$10.6 million in 2022, then skyrocketed by 87.48% to -$1.3 million in 2023, then soared by 64.49% to -$473000.0 in 2024, then crashed by 447.19% to -$2.6 million in 2025.
  • Per Business Quant, the three most recent readings for HCTI's EBITDA are -$2.6 million (Q3 2025), -$1.4 million (Q2 2025), and -$1.4 million (Q1 2025).